Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalbuphine as an adjuvant to levobupivacaine scalp nerve block in elective supratentorial craniotomy
TCTR20221124002Phase 4Completed
- Sponsor
- Department of Anesthesiology, King Chulalongkorn Memorial Hospital
- Start
- Jul 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of nalbuphine in postoperative pain, Post-craniotomy headache (PCH), sponsored by Department of Anesthesiology, King Chulalongkorn Memorial Hospital. Started Jul 2021; status: completed.
02
Drugs
nalbuphine
03
Conditions
postoperative painPost-craniotomy headache (PCH)
Beyond the preview
Go deeper on TCTR20221124002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221124002.